Recent filings for Becton Dickinson & Co. (BDX) highlight notable insider movements. On November 7, 2025, Director Scott Bertram L sold 217 shares of the company in a transaction valued at $38,318, priced at $176.58 per share. Following the sale, Bertram now retains 35,816 shares, amounting to an estimated value of $7.0 million.
Shortly after, Bertram Scott purchased 217 shares, generating total proceeds of $38,318, signaling continued personal investment in the company.
In an earlier transaction, Feld Michael, BDX’s EVP & President of Life Sciences, sold 57 shares for a total of $10,603, executed at a price of $186.01 per share. As a result, Feld now owns 8,245 shares, valued at approximately $1.61 million.
These insider transactions offer insight into management’s ongoing engagement with the company’s performance and stock valuation.
Analyst Coverage and Rating Adjustments
Analyst activity for BDX has been particularly active throughout 2025. On September 25, 2025, RBC Capital Markets initiated coverage with a Sector Perform rating and issued a price target of $211. Earlier in the year, Citigroup downgraded BDX in late May from Buy to Neutral, citing shifting industry and company conditions.
On May 2, 2025, Raymond James lowered its rating from Outperform to Market Perform, while Piper Sandler also revised its outlook the same day, moving from Overweight to Neutral. The cluster of downgrades suggests cautious sentiment from analysts as the company navigates evolving market pressures.
Price Performance Review of BDX
On Tuesday, Becton Dickinson & Co.’s stock rose 2.37%, closing at $195.49. Over the past five trading days, BDX has gained 1.64%, marking a modest upward movement. Despite these gains, the stock has declined 13.29% year-to-date and is down 13.83% over the past 12 months, reflecting ongoing volatility.
BDX reached a 52-week high of $251.99 on February 3, 2025, while its 52-week low of $162.29 occurred on November 6, 2025. These wide price swings highlight the challenging landscape the company has faced across the year.
Support and Resistance Levels to Watch
Technical indicators show key price levels for investors monitoring BDX. The stock currently has support at $192.61, and a break below this could push the price further down to $189.74. On the upside, resistance is identified at $196.96, with a secondary resistance level at $198.44. These markers will play an important role in determining near-term mobility for the stock.
Short Interest Trends: Rising Bearish Pressure
Short interest in Becton Dickinson & Co. saw a sharp rise as of November 14, 2025, increasing by 0.9 million shares to a total of 4.18 million shares. According to recent data, short interest in mid-October stood at 3.28 million shares, reflecting a 21.49% increase.
Despite the rise—typically signaling bearish positioning—the report suggests positive sentiment, possibly indicating expectations of a rebound or an undervalued opportunity in the stock. Short interest trends will remain a key indicator of market confidence going forward.
